Comorbid polycystic ovarian syndrome in idiopathic intracranial hypertension

Mark Thaller; Nicola Adderley; Anuradhaa Subramanian; Susan Mollan; Alex Sinclair

doi:10.1080/01658107.2022.2162089

Comorbid polycystic ovarian syndrome in idiopathic intracranial hypertension

Mark Thaller, Nicola Adderley, Anuradhaa Subramanian, Susan Mollan, Alex Sinclair^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

8 Downloads (Pure)

Abstract

The link between polycystic ovarian syndrome (PCOS) and idiopathic intracranial hypertension (IIH) has long been debated. Historically, there is a wide range of reported occurrence of both conditions, being between 15% and 64%. Both conditions share a common phenotype. The awareness that in a new large data study that there is a 1.5-fold increased prevalence of diagnosed PCOS in participants with IIH as compared to the controls is important. Assessment for the potential of co-morbid PCOS in women with IIH is important as this may enable optimisation of weight and fertility management.

Original language	English
Pages (from-to)	49-52
Number of pages	4
Journal	Neuro-Ophthalmology
Volume	47
Issue number	1
DOIs	https://doi.org/10.1080/01658107.2022.2162089
Publication status	Published - 10 Jan 2023

Access to Document

10.1080/01658107.2022.2162089Licence: None: All rights reserved

ThallerM2023Co-morbid_AAM
This is an Accepted Manuscript of an article published by Taylor & Francis in Mark Thaller, Nicola J. Adderley, Anuradhaa Subramanian, Susan P. Mollan & Alexandra J. Sinclair (2023) 'Co-morbid Polycystic Ovarian Syndrome with Idiopathic Intracranial Hypertension', Neuro-Ophthalmology, 47:1, 49-52, on 10/01/2023, available at DOI: 10.1080/01658107.2022.2162089
Accepted author manuscript, 165 KBLicence: Other (please specify with Rights Statement)

Cite this

@article{632c4224341e4cb7a8ba2b079616b112,

title = "Comorbid polycystic ovarian syndrome in idiopathic intracranial hypertension",

abstract = "The link between polycystic ovarian syndrome (PCOS) and idiopathic intracranial hypertension (IIH) has long been debated. Historically, there is a wide range of reported occurrence of both conditions, being between 15% and 64%. Both conditions share a common phenotype. The awareness that in a new large data study that there is a 1.5-fold increased prevalence of diagnosed PCOS in participants with IIH as compared to the controls is important. Assessment for the potential of co-morbid PCOS in women with IIH is important as this may enable optimisation of weight and fertility management.",

author = "Mark Thaller and Nicola Adderley and Anuradhaa Subramanian and Susan Mollan and Alex Sinclair",

year = "2023",

month = jan,

day = "10",

doi = "10.1080/01658107.2022.2162089",

language = "English",

volume = "47",

pages = "49--52",

journal = "Neuro-Ophthalmology",

issn = "0165-8107",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Comorbid polycystic ovarian syndrome in idiopathic intracranial hypertension

AU - Thaller, Mark

AU - Adderley, Nicola

AU - Subramanian, Anuradhaa

AU - Mollan, Susan

AU - Sinclair, Alex

PY - 2023/1/10

Y1 - 2023/1/10

N2 - The link between polycystic ovarian syndrome (PCOS) and idiopathic intracranial hypertension (IIH) has long been debated. Historically, there is a wide range of reported occurrence of both conditions, being between 15% and 64%. Both conditions share a common phenotype. The awareness that in a new large data study that there is a 1.5-fold increased prevalence of diagnosed PCOS in participants with IIH as compared to the controls is important. Assessment for the potential of co-morbid PCOS in women with IIH is important as this may enable optimisation of weight and fertility management.

AB - The link between polycystic ovarian syndrome (PCOS) and idiopathic intracranial hypertension (IIH) has long been debated. Historically, there is a wide range of reported occurrence of both conditions, being between 15% and 64%. Both conditions share a common phenotype. The awareness that in a new large data study that there is a 1.5-fold increased prevalence of diagnosed PCOS in participants with IIH as compared to the controls is important. Assessment for the potential of co-morbid PCOS in women with IIH is important as this may enable optimisation of weight and fertility management.

U2 - 10.1080/01658107.2022.2162089

DO - 10.1080/01658107.2022.2162089

M3 - Comment/debate

SN - 0165-8107

VL - 47

SP - 49

EP - 52

JO - Neuro-Ophthalmology

JF - Neuro-Ophthalmology

IS - 1

ER -

Comorbid polycystic ovarian syndrome in idiopathic intracranial hypertension

Abstract

Access to Document

Fingerprint

Cite this